Skip to main content
PLRZ
NASDAQ Industrial Applications And Services

Polyrizon Prices $3.15M Registered Direct Offering at $12.00/Share

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$11.01
Mkt Cap
$26.175M
52W Low
$2.88
52W High
$18.2
52W Position info
282% above low
Off High info
40% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

PLRZ has more than doubled off its 52-week low of $2.88 on elevated volume (2.2× avg).

Summary

Polyrizon priced a $3.15M registered direct offering at $12.00/share with a concurrent private placement of warrants, raising approximately $3.5M net for general corporate purposes.


Key Events · Financing and Capital Events · PLRZ

  • Registered Direct Offering Priced

    232,500 ordinary shares at $12.00 per share plus 30,000 pre-funded warrants at $11.99999 each, totaling approximately $3.15 million in gross proceeds.

  • Concurrent Private Placement

    70,833 PIPE pre-funded warrants and 333,333 ordinary share warrants at $12.00 exercise price, adding potential dilution of 404,166 shares.

  • Dilution Impact

    Registered offering represents approximately 12.3% of outstanding shares; combined with private placement warrants, total potential dilution exceeds 18%.

  • Placement Agent Terms

    Aegis Capital Corp. receives 8% cash fee ($251,999.98) plus $75,000 legal reimbursement; 45-day insider lock-up and 30-day company standstill apply.


Analysis · PLRZ · Industrial Applications And Services

Polyrizon is raising approximately $3.5 million in net proceeds through a registered direct offering and concurrent private placement. The offering price of $12.00 per share represents a modest discount to the last reported sale price of $12.51 on September 2, 2026. The deal includes 232,500 ordinary shares, 30,000 pre-funded warrants, and unregistered warrants for an additional 404,166 shares. Existing shareholders face dilution of approximately 12.3% from the registered portion alone, with additional potential dilution from the private placement warrants. The capital extends the company's runway as it advances its NASARIX clinical program, but the warrant structure creates meaningful overhang.

How filings like this one have moved

In the 30 days to Sep 10, 2026, 30% of the 1973 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PLRZ was trading at $11.01 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $26.2M. The 52-week trading range was $2.88 to $18.20. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PLRZ - Latest Insights

PLRZ
Sep 04, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $10.81
Real-time Price: $11.10 info
Change: +$0.2882 (+3%) info
Market Cap: $26.33M info
PLRZ
Sep 04, 2026, 9:19 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $11.01
Real-time Price: $11.10 info
Change: +$0.090 (+0.82%) info
Market Cap: $26.33M info
PLRZ
Sep 03, 2026, 8:50 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $12.01
Real-time Price: $11.10 info
Change: -$0.910 (-8%) info
Market Cap: $26.33M info
PLRZ
Sep 02, 2026, 7:32 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $14.22
Real-time Price: $11.10 info
Change: -$3.12 (-22%) info
Market Cap: $26.33M info
PLRZ
Aug 20, 2026, 4:00 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $10.96
Real-time Price: $11.10 info
Change: +$0.140 (+1%) info
Market Cap: $26.33M info